Eton Pharmaceuticals Inc

NASDAQ:ETON   3:59:54 PM EDT
3.45
-0.12 (-3.36%)
Products

Eton Pharmaceuticals Inc - Received Notice From The UK-Based Manufacturer Of Its Zonisamide Oral Suspension Product Candidate

Published: 12/21/2021 21:30 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Inc - Received Notice From the United Kingdom-based Manufacturer of Its Zonisamide Oral Suspension Product Candidate.
Eton Pharmaceuticals - Believes FDA's Decision on Zonisamide Product May Be Received After Target Action Date Due to Time Needed to Complete Facility Inspection.
Eton Pharmaceuticals Inc - Notice Says U.S. FDA Has Scheduled an On-site Inspection of the Facility Beginning on January 27, 2022.
Eton Pharmaceuticals - Continues to Believe Inspection of Manufacturing Site is Only Open Item Holding Up Approval of NDA for Zonisamide Product.